TrialRMD open2025

Deciphering differential biomarkers for anti-interleukin-6 receptor and anti-tumour necrosis factor-α treatment response in rheumatoid arthritis by multiomics analysis.

Inoncent Agueusop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.